This invention belongs to the field of pharmaceutical formulations and relates to a compound ophthalmic in-situ gel composition for treating ocular
Demodex mite infection, its preparation method, and its application. By weight percentage, the compound ophthalmic in-situ gel composition for treating ocular
Demodex mite infection comprises 0.1-2.0% of a
nitroimidazole compound, 0.05-3.0% of an isoxazoline compound, 0.1-1.5% of a gelling
polymer, 1.0-8.0% of a complex solubilizing
system, 0.1-3.0% of pharmaceutically acceptable excipients, and the balance being water. The complex solubilizing
system includes
polyvinylpyrrolidone and
cyclodextrin derivatives. This invention effectively solves the problem of poor
solubility of isoxazoline drugs through a complex solubilizing
system, and the combination of the two drugs has a significant synergistic acaricidal effect. Combined with a gelling
polymer, it can achieve in-situ gelation on the
ocular surface, prolong retention, and sustained
drug release, with low
ocular irritation, providing a highly effective, long-lasting, and safe new local treatment option for
Demodex mite-related eye diseases.